Ferring Pharmaceuticals announces new Board Member
-Ferring Pharmaceuticals announced today that Dr. John Patterson CBE FRCP has been appointed as a new Board Member with immediate effect…
Frost & Sullivan Accolade for Ferring Pharmaceuticals
-The 2008 Frost & Sullivan European Human Growth Hormone Competitive Strategy Leadership Award is presented to Ferring Pharmaceuticals…
FIRMAGON® (degarelix) is launched in Europe for the treatment of advanced prostate cancer
-Today marks the European launch of FIRMAGON® (degarelix), a new treatment option in hormonal therapy for prostate cancer…
Ferring Pharmaceuticals creates Executive Board
-Today, Ferring Pharmaceuticals announced the creation of a new Executive Board…
European Commission grants Ferring Pharmaceuticals approval of FIRMAGON® (degarelix) for treatment of prostate cancer
-Ferring Pharmaceuticals announced today that it has received marketing authorisation from the European Commission, for FIRMAGON® (degarelix)…
Archives Press release 2009
Archives Press release 2009